These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35836753)

  • 1. Statin-induced Liver Injury Patterns: A Clinical Review.
    Averbukh LD; Turshudzhyan A; Wu DC; Wu GY
    J Clin Transl Hepatol; 2022 Jun; 10(3):543-552. PubMed ID: 35836753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network.
    Russo MW; Hoofnagle JH; Gu J; Fontana RJ; Barnhart H; Kleiner DE; Chalasani N; Bonkovsky HL
    Hepatology; 2014 Aug; 60(2):679-86. PubMed ID: 24700436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced liver injury associated with statins.
    Russo MW; Scobey M; Bonkovsky HL
    Semin Liver Dis; 2009 Nov; 29(4):412-22. PubMed ID: 19826975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe acute cholestatic hepatitis with prolonged cholestasis and bile-duct injury following atorvastatin therapy: a case report.
    Rahier JF; Rahier J; Leclercq I; Geubel AP
    Acta Gastroenterol Belg; 2008; 71(3):318-20. PubMed ID: 19198578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitor use in chronic liver disease: a therapeutic controversy.
    Tzefos M; Olin JL
    J Clin Lipidol; 2011; 5(6):450-9. PubMed ID: 22108148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin Therapy: Review of Safety and Potential Side Effects.
    Ramkumar S; Raghunath A; Raghunath S
    Acta Cardiol Sin; 2016 Nov; 32(6):631-639. PubMed ID: 27899849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy.
    Conforti A; Magro L; Moretti U; Scotto S; Motola D; Salvo F; Ros B; Leone R
    Drug Saf; 2006; 29(12):1163-72. PubMed ID: 17147462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-HMG-CoA reductase myopathy, an undesirable evolution of statin induced myopathy: a case report.
    Upreti S; Fayyaz B; Bongu RP
    J Community Hosp Intern Med Perspect; 2019; 9(1):33-35. PubMed ID: 30788073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of statin-induced liver injury with positive rechallenge with a second statin. Is there a class effect?
    Onfiani G; Nascimbeni F; Carubbi F
    J Basic Clin Physiol Pharmacol; 2021 Apr; 32(6):1151-1155. PubMed ID: 33882199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same?
    Evans M; Rees A
    Drug Saf; 2002; 25(9):649-63. PubMed ID: 12137559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of statins in patients with liver disease.
    Kalaitzakis E; Björnsson ES
    Minerva Gastroenterol Dietol; 2014 Mar; 60(1):15-24. PubMed ID: 24632765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins and Abnormal Liver Function Tests: Is There a Correlation?
    Ashraf J; Ali Khan M; Minhaj S; Khatti S; Aarij KM; Shehzad M; Khan TM
    Cureus; 2020 Aug; 12(8):e10145. PubMed ID: 33014643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rare case of cefepime-induced cholestatic liver injury.
    Liao PF; Wu YK; Huang KL; Chen HY
    Ci Ji Yi Xue Za Zhi; 2019; 31(2):124-128. PubMed ID: 31007494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin-Associated Side Effects.
    Thompson PD; Panza G; Zaleski A; Taylor B
    J Am Coll Cardiol; 2016 May; 67(20):2395-2410. PubMed ID: 27199064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Update on Drug-induced Liver Injury.
    Devarbhavi H
    J Clin Exp Hepatol; 2012 Sep; 2(3):247-59. PubMed ID: 25755441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin safety: an overview and assessment of the data--2005.
    Bays H
    Am J Cardiol; 2006 Apr; 97(8A):6C-26C. PubMed ID: 16581330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin-associated psychiatric adverse events: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting.
    Tuccori M; Lapi F; Testi A; Coli D; Moretti U; Vannacci A; Motola D; Salvo F; Rivolta AL; Blandizzi C; Mugelli A; Del Tacca M
    Drug Saf; 2008; 31(12):1115-23. PubMed ID: 19026028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Case of Carbamazepine-induced Severe Cholestatic Hepatitis: Case Report and Review of Literature.
    Ganesh S; Shukla L; Kandasamy A; Benegal V
    Indian J Psychol Med; 2017; 39(5):688-690. PubMed ID: 29200572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription of statins to dyslipidemic patients affected by liver diseases: a subtle balance between risks and benefits.
    Anfossi G; Massucco P; Bonomo K; Trovati M
    Nutr Metab Cardiovasc Dis; 2004 Aug; 14(4):215-24. PubMed ID: 15553600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin-associated incident diabetes: a literature review.
    Park ZH; Juska A; Dyakov D; Patel RV
    Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.